Education
About Us
Working with TipRanks
Follow Us
CARsgen Therapeutics Holdings Ltd. (HK:2171)
:2171
RESEARCH TOOLSreports
Total Valuation
CARsgen Therapeutics Holdings Ltd. has a market cap or net worth of HK$11.51B. The enterprise value is HK$5.15B.
Market CapHK$11.51B
Enterprise ValueHK$5.15B
Share Statistics
CARsgen Therapeutics Holdings Ltd. has 575,725,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding575,725,950
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CARsgen Therapeutics Holdings Ltd.’s return on equity (ROE) is -0.76 and return on invested capital (ROIC) is -55.66%.
Return on Equity (ROE)-0.76
Return on Assets (ROA)-0.48
Return on Invested Capital (ROIC)-55.66%
Return on Capital Employed (ROCE)-0.57
Revenue Per Employee84.78K
Profits Per Employee-1.72M
Employee Count465
Asset Turnover0.02
Inventory Turnover3.56
Valuation Ratios
The current PE Ratio of CARsgen Therapeutics Holdings Ltd. is -5.99. CARsgen Therapeutics Holdings Ltd.’s PEG ratio is 0.10.
PE Ratio-5.99
PS Ratio0.00
PB Ratio2.95
Price to Fair Value4.53
Price to FCF-9.33
Price to Operating Cash Flow-11.35
PEG Ratio0.10
Income Statement
In the last 12 months, CARsgen Therapeutics Holdings Ltd. had revenue of 39.42M and earned -798.13M in profits. Earnings per share was -1.44.
Revenue39.42M
Gross Profit14.75M
Operating Income-808.19M
Pretax Income-797.79M
Net Income-798.13M
EBITDA-495.01M
Earnings Per Share (EPS)-1.44
Cash Flow
In the last 12 months, operating cash flow was -409.69M and capital expenditures 0.00, giving a free cash flow of -409.69M billion.
Operating Cash Flow-409.69M
Free Cash Flow-409.69M
Free Cash Flow per Share-0.71
Dividends & Yields
CARsgen Therapeutics Holdings Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.55
52-Week Price Change305.05%
50-Day Moving Average17.14
200-Day Moving Average10.24
Relative Strength Index (RSI)67.56
Average Volume (3m)2.80M
Important Dates
CARsgen Therapeutics Holdings Ltd. upcoming earnings date is Aug 26, 2025, TBA Not Confirmed.
Last Earnings DateMar 18, 2025
Next Earnings DateAug 26, 2025
Ex-Dividend Date―
Financial Position
CARsgen Therapeutics Holdings Ltd. as a current ratio of 6.02, with Debt / Equity ratio of 4.83%
Current Ratio6.02
Quick Ratio6.00
Debt to Market Cap0.02
Net Debt to EBITDA2.65
Interest Coverage Ratio-141.47
Taxes
In the past 12 months, CARsgen Therapeutics Holdings Ltd. has paid 346.00K in taxes.
Income Tax346.00K
Effective Tax Rate>-0.01
Enterprise Valuation
CARsgen Therapeutics Holdings Ltd. EV to EBITDA ratio is -7.01, with an EV/FCF ratio of -8.08.
EV to Sales88.01
EV to EBITDA-7.01
EV to Free Cash Flow-8.08
EV to Operating Cash Flow-8.47
Balance Sheet
CARsgen Therapeutics Holdings Ltd. has HK$1.48B in cash and marketable securities with ¥166.42M in debt, giving a net cash position of -HK$1.31B billion.
Cash & Marketable SecuritiesHK$1.48B
Total Debt¥166.42M
Net Cash-HK$1.31B
Net Cash Per Share-HK$2.28
Tangible Book Value Per ShareHK$1.91
Margins
Gross margin is 0.00%, with operating margin of -2049.95%, and net profit margin of -2024.43%.
Gross Margin0.00%
Operating Margin-2049.95%
Pretax Margin-2023.55%
Net Profit Margin-2024.43%
EBITDA Margin-1255.57%
EBIT Margin-1427.19%
Analyst Forecast
The average price target for CARsgen Therapeutics Holdings Ltd. is HK$10.01, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price TargetHK$10.01
Price Target Upside-53.66% Downside
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast-4.33%